检查 多种新型血清和尿液生物标志物有望成为急性肾损伤的诊断和分类指标。[11]Parikh CR, Lu JC, Coca SG, et al. Tubular proteinuria in acute kidney injury: a critical evaluation of current status and future promise. Ann Clin Biochem. 2010 Jul;47(Pt 4):301-12.http://journals.sagepub.com/doi/full/10.1258/acb.2010.010076http://www.ncbi.nlm.nih.gov/pubmed/20511371?tool=bestpractice.com[12]Makris K, Spanou L. Acute kidney injury: diagnostic approaches and controversies. Clin Biochem Rev. 2016 Dec;37(4):153-175.https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5242479/http://www.ncbi.nlm.nih.gov/pubmed/28167845?tool=bestpractice.com 肾损伤分子 1 (kidney injury molecule-1, KIM-1) 已被证明是缺血性 ATN 良好的早期生物标志物。[13]Waring WS, Moonie A. Earlier recognition of nephrotoxicity using novel biomarkers of acute kidney injury. Clin Toxicol (Phila). 2011 Oct;49(8):720-8.http://www.ncbi.nlm.nih.gov/pubmed/21970770?tool=bestpractice.com[14]Huang Y, Don-Wauchope AC. The clinical utility of kidney injury molecule 1 in the prediction, diagnosis and prognosis of acute kidney injury: a systematic review. Inflamm Allergy Drug Targets. 2011 Aug;10(4):260-71.http://www.ncbi.nlm.nih.gov/pubmed/21539514?tool=bestpractice.com 其他生物标志物包括中性粒细胞明胶酶相关脂质运载蛋白 (neutrophil gelatinase-associated lipocalin, NGAL) 和白细胞介素-18 (interleukin-18, IL-18)。[15]Clerico A, Galli C, Fortunato A, et al. Neutrophil gelatinase-associated lipocalin (NGAL) as biomarker of acute kidney injury: a review of the laboratory characteristics and clinical evidences. Clin Chem Lab Med. 2012 Feb 15;50(9):1505-17.http://www.ncbi.nlm.nih.gov/pubmed/22962216?tool=bestpractice.com[16]Puthumana J, Ariza X, Belcher JM, et al. Urine interleukin 18 and lipocalin 2 are biomarkers of acute tubular necrosis in patients with cirrhosis: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2017 Jul;15(7):1003-1013.e3.http://www.ncbi.nlm.nih.gov/pubmed/28013112?tool=bestpractice.com